Related Experiment Video
Updated: Feb 18, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
Magdalena Jankowska1,2, Mathias Haarhaus1, Abdul Rashid Qureshi1
1Division of Renal Medicine and Baxter Novum, Karolinska University Hospital at Huddinge, Karolinska Institutet, Stockholm, Sweden.
Introduction:
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease originating from a mutation in genes encoding polycystin 1 and 2. Recent evidence suggests that these polycystins mediate mechanosensation not only in the primary cilium of kidney cells but also in bone cells. The Wnt/β-catenin signaling pathway plays a central role in mechanotransduction in osteocytes. Mechanical unloading causes the upregulation of the Wnt inhibitor sclerostin. We tested the hypothesis that ADPKD associates with higher circulating sclerostin levels.
Methods:
In this observational, cross-sectional study, circulating levels of sclerostin and other laboratory parameters of mineral and bone disease, including intact parathyroid hormone (PTH), calcium, phosphate, magnesium, 25(OH) D-vitamin, 1,25 (OH)2 D-vitamin, and bone specific alkaline phosphatase (BALP) were assessed in 100 patients with end-stage renal disease recruited from an ongoing longitudinal cohort study in Stockholm, Sweden.
Results:
Patients with ADPKD had higher sclerostin levels and lower BALP levels as compared to patients with other primary renal disease. In multivariate analysis, ADPKD associated with circulating sclerostin levels, independent of the established determinants including age, gender, body mass index, diabetes, phosphate, PTH, and 1,25 (OH)2 D-vitamin.
Discussion:
Circulating sclerostin levels are increased in ADPKD, possibly reflecting impaired mechanosensation. The clinical relevance of this finding, especially with regard to bone health, remains to be investigated. Our finding draws attention to the etiology of kidney disease as an important, yet neglected, confounder of the association between renal failure and mineral and bone disease.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) is linked to elevated sclerostin levels, potentially indicating impaired bone cell mechanosensation. This finding highlights the importance of kidney disease etiology in understanding bone health in renal failure patients.
Area of Science:
- Nephrology
- Endocrinology
- Bone Biology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) involves mutations in polycystin genes, affecting mechanosensation in kidney and bone cells.
- The Wnt/β-catenin pathway is crucial for osteocyte mechanotransduction, with mechanical unloading upregulating sclerostin.
- Sclerostin is a key inhibitor of bone formation, influenced by mechanical forces.
Purpose of the Study:
- To investigate the association between ADPKD and circulating sclerostin levels.
- To determine if ADPKD is an independent determinant of sclerostin levels in patients with end-stage renal disease.
Main Methods:
- Observational, cross-sectional study of 100 end-stage renal disease patients.
- Assessed circulating sclerostin and other mineral and bone disease parameters (PTH, calcium, phosphate, etc.).
- Utilized multivariate analysis to identify independent associations.
Main Results:
- Patients with ADPKD exhibited significantly higher sclerostin levels compared to non-ADPKD patients.
- ADPKD was independently associated with increased sclerostin levels, irrespective of other factors.
- Lower bone specific alkaline phosphatase (BALP) levels were observed in ADPKD patients.
Conclusions:
- Circulating sclerostin levels are elevated in ADPKD, suggesting potential impaired mechanosensation in bone.
- The findings underscore the significance of kidney disease etiology in confounding the relationship between renal failure and mineral and bone disease.
- Further research is needed to clarify the clinical implications for bone health in ADPKD patients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrons
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Kidney Disease III: Interprofessional Care
Regulation of Nuclear Protein Sorting

